news paper icon

Analyzed News

REFILE-FDA declines to approve Evolus Inc's rival treatment to Botox

May 16 (Reuters) - U.S. health regulators on Wednesday declined to approve Evolus Inc's rival product to Allergan Plc's Botox, citing certain deficiencies related to its potential treatment for frown lines. [Source]

Publication Date:


Category: companyNews

Topics: inc's, treatment, botox, rival, evolus

Source Link:

Related Articles